MedinCell S.A. (EPA:MEDCL)
France · Delayed Price · Currency is EUR 24.88
+0.76 (3.15%)
Aug 21, 2026, 5:35 PM CET
MedinCell Balance Sheet
Financials in millions EUR. Fiscal year is April - March.
Millions EUR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 62.79 | 59.04 | 19.46 | 6.47 | 24.62 |
Short-Term Investments | 22.03 | 12.86 | - | 0 | 1.97 |
Cash & Short-Term Investments | 84.82 | 71.9 | 19.46 | 6.47 | 26.59 |
Cash Growth | 17.98% | 269.46% | 200.77% | -75.67% | -46.69% |
Accounts Receivable | 4.5 | 3.15 | 2.25 | 2.09 | 0.8 |
Other Receivables | 5.86 | 4.52 | 4.46 | 10.18 | 4.88 |
Receivables | 10.35 | 7.67 | 6.71 | 12.27 | 5.68 |
Prepaid Expenses | 1.33 | 0.94 | 0.97 | 0.74 | 1.14 |
Other Current Assets | 0.24 | 0.11 | 0.12 | 0.08 | 0.67 |
Total Current Assets | 96.74 | 80.62 | 27.26 | 19.57 | 34.07 |
Property, Plant & Equipment | 5 | 5.27 | 5.43 | 6.37 | 7.03 |
Long-Term Investments | 0.03 | 0.02 | 0.02 | 0.02 | 1.27 |
Other Intangible Assets | 3.48 | 2.65 | 2.45 | 1.93 | 1.67 |
Other Long-Term Assets | 2.82 | 1.89 | 1.79 | 1.45 | 0.26 |
Total Assets | 108.06 | 90.45 | 36.95 | 29.34 | 44.3 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 3.39 | 4 | 1.85 | 4.18 | 2.98 |
Accrued Expenses | 7.15 | 5.07 | 3.15 | 2.48 | 1.42 |
Current Portion of Long-Term Debt | 2.64 | 6.62 | 5.52 | 42.81 | 27.76 |
Current Portion of Leases | 0.67 | 0.67 | 0.64 | 0.64 | 0.58 |
Current Unearned Revenue | 6.63 | 13.38 | 5.18 | 5.78 | 5.29 |
Other Current Liabilities | 0.24 | 0.13 | 0.13 | 1.13 | 0.21 |
Total Current Liabilities | 20.71 | 29.87 | 16.47 | 57.03 | 38.24 |
Long-Term Debt | 66.89 | 57.98 | 56.29 | 11.71 | 16.25 |
Long-Term Leases | 1.72 | 2.05 | 2.26 | 2.54 | 2.9 |
Pension & Post-Retirement Benefits | 0.45 | 0.36 | 0.37 | 0.35 | 0.27 |
Other Long-Term Liabilities | 15.22 | 16.56 | 2.4 | 0 | 0.02 |
Total Liabilities | 104.99 | 106.82 | 77.77 | 71.63 | 57.67 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 0.36 | 0.33 | 0.29 | 0.25 | 0.25 |
Additional Paid-In Capital | 45.44 | 70.73 | 31.01 | 7.42 | 6.91 |
Retained Earnings | -31.29 | -18.44 | -25.04 | -32.01 | -24.81 |
Comprehensive Income & Other | -11.45 | -68.99 | -47.09 | -17.95 | 4.27 |
Total Common Equity | 3.06 | -16.37 | -40.82 | -42.29 | -13.37 |
Shareholders' Equity | 3.06 | -16.37 | -40.82 | -42.29 | -13.37 |
Total Liabilities & Equity | 108.06 | 90.45 | 36.95 | 29.34 | 44.3 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 71.92 | 67.32 | 64.71 | 57.71 | 47.49 |
Net Cash (Debt) | 12.91 | 4.58 | -45.25 | -51.24 | -20.9 |
Net Cash Growth | 182.10% | - | - | - | - |
Net Cash Per Share | 0.39 | 0.15 | -1.59 | -2.03 | -0.84 |
Filing Date Shares Outstanding | 35.91 | 33.08 | 29.09 | 28.71 | 25.11 |
Total Common Shares Outstanding | 35.91 | 33.07 | 29.07 | 25.28 | 25.11 |
Working Capital | 76.02 | 50.74 | 10.79 | -37.46 | -4.17 |
Book Value Per Share | 0.09 | -0.49 | -1.40 | -1.67 | -0.53 |
Tangible Book Value | -0.42 | -19.01 | -43.27 | -44.22 | -15.04 |
Tangible Book Value Per Share | -0.01 | -0.58 | -1.49 | -1.75 | -0.60 |
Machinery | 9.09 | 8.28 | 7.64 | 7.36 | 7.14 |
Construction In Progress | - | 0.06 | 0.04 | 0.26 | 0.13 |